LANCE HARRELL: Open Payments
NPI 1447407671 · WEST MEMPHIS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 13 payments from 8 companies in 2025. Trend: 2023 $243 · 2024 $125 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $59 |
| Abbott Laboratories | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Ascensia Diabetes Care Us Inc. | 1 | $31 |
| Amgen Inc. | 2 | $30 |
| Seqirus USA Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
Products named: LINZESS, FREESTYLE LIBRE 3, Flucelvax, BREZTRI, The Cologuard Plus Collection Kit, Wegovy, QULIPTA, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
